This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Jérémy Pratt
Introduction
Jérémy Pratt is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of cerebral edemas. His innovative approach has led to the development of a patent that addresses a critical health issue.
Latest Patents
Jérémy Pratt holds a patent for the "Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas." This patent highlights the effectiveness of administering low molecular weight heparin to prevent and treat cerebral edema, a condition that can have serious health implications.
Career Highlights
Pratt is associated with Aventis Pharma S.A., a prominent pharmaceutical company. His work at Aventis Pharma has allowed him to focus on groundbreaking research and development in the medical field. His dedication to innovation has positioned him as a key figure in his area of expertise.
Collaborations
Throughout his career, Jérémy Pratt has collaborated with esteemed colleagues such as André Uzan and Jean-Marie Stutzman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
Jérémy Pratt's contributions to the field of medicine through his patent and collaborations demonstrate his commitment to innovation. His work continues to impact the treatment of cerebral edemas, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile